Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma.

Adv Radiat Oncol · 2025 · PMC12446645 · PMID 40979684

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendP = .08so close (0.05 < p ≤ 0.1)

Interestingly, the hyperfractionated regimen of 30 Gy in 10 fractions showed a trend toward being more effective for symptom palliation when compared to the hypofractionated regimen of 20 Gy in 5 ( P = .08; Table E2 , Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.